Chuanxin Biomedical (Suzhou) Co., Ltd. announced that it has received CNY 150,000,000 in a round of funding on June 29, 2023. The transaction included participation from new investor Changchun BCHT Biotechnology Co.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
34 CNY | -1.13% | -4.76% | -37.97% |
EPS Revisions
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-37.97% | 1.94B | |
+15.54% | 78.51B | |
+12.05% | 9B | |
+58.17% | 4.96B | |
-14.94% | 4.84B | |
-.--% | 3.72B | |
+21.94% | 2.48B | |
-26.63% | 2.19B | |
+16.75% | 2.12B | |
-0.50% | 1.64B |
- Stock Market
- Equities
- 688276 Stock
- News Changchun BCHT Biotechnology Co.
- Chuanxin Biomedical Co., Ltd. announced that it has received CNY 150 million in funding from Changchun BCHT Biotechnology Co.